Definitive Contract 75F40118C10201
Award Date
9/26/18
Potential Completion Date
2/28/23
Potential Value
$5.6M
Federal Agency
Food and Drug Administration
Awardee
Kaiser Foundation Hospitals
Ultimate Awardee
Kaiser Foundation Health Plan, Inc.
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Oakland, CA 94612, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, was awarded a $24,999 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations. To be performed in Rockville, Maryland through August 2024, this contract has no set-aside designation and is likely to facilitate research support services aligned with Kaiser Permanente's capabilities and...
This federal contract award to Kaiser Foundation Hospitals, a division of the non-profit Kaiser Permanente healthcare system, is for biomedical research valued at $53,167,915.85. The award, made by the National Heart Lung and Blood Institute, a part of the National Institutes of Health, is a definitive contract with a cost-no-fee pricing type that runs through June 30, 2013. This contract does not have a set-aside designation. Kaiser Foundation Hospitals and its parent company, Kaiser Foundation...
This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., was issued by the Food and Drug Administration (FDA) to examine the impact of a benzodiazepine (BZD) care plan and electronic health record BZD prescribing on BZD prescribing, in parallel with provider education. The $1,233,980 definitive, firm-fixed-price contract has a period of performance through September 29, 2026. The contract was awarded pursuant to a Broad Agency...
This is a $2,265,272.19 definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a study entitled "Suicide-Related Risks Associated with Prescription Opioid Deprescribing". The contract was awarded on August 28, 2019 with a completion date of September 15, 2022. The contract involves Kaiser Permanente serving as the prime contractor, with subcontractors including...
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract has a ceiling value of $42,304,985.02 and is a definitive contract with a cost-no-fee pricing type. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. Kaiser Permanente is a large, non-profit healthcare provider and...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a firm fixed price purchase order valued at $19,827.67 by the National Institutes of Health's National Institute on Drug Abuse. The contract is for Kaiser Permanente to finalize project objectives and scope for a patient cohort study, including eligibility criteria and intended outcomes. Performance will take place in Baltimore, Maryland over a one year period from...
This federal contract award, valued at $350,000.00, was issued by the Agency for Healthcare Research and Quality (AHRQ) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a prominent non-profit healthcare provider and research organization. The contract is for "METHODS AND DISSEMINATION: COLLABORATION TO IMPROVE VALIDITY, CONSISTENCY, AND UTILITY OF SYSTEMATIC REVIEWS" and is a delivery order under the Evidence-based Practice Centers VI (EPC VI) indefinite delivery...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to provide services leveraging electronic health records. The contract has a period of performance of just under one year, running from September 2023 through September 2024. Work will be conducted in Baltimore,...
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm fixed-price purchase order to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, a non-profit healthcare provider, to conduct research on "KAISER RISK OF NEW MALIGNANCIES FOLLOWING BREAST CANCER." The contract has a potential value of $149,990.00 and a period of performance ending on August 31, 2018. No...
This federal contract award is for $15,000.00 and was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data services. The contract has an ultimate completion date of September 22, 2025 and is a firm fixed-price purchase order. Kaiser Foundation Hospitals is a prominent non-profit healthcare provider and research organization that has extensive expertise in medical research, clinical studies, and public health initiatives....